Introduction: India is claimed to be the diabetes capital of the world. Many studies had proven that persistent hyperglycemia and associated metabolic syndrome features like hypertension, dyslipidemia, and obesity contribute to the development of vascular complications. The risk of chronic complications increases as a function of the duration of hyperglycemia; they usually become apparent in the second decade of hyperglycemia. Since type II diabetes mellitus (DM) often has a long asymptomatic period of hyperglycemia, many individuals with type II DM have complications at the time of diagnosis. The vascular complications of DM are subdivided into microvascular (retinopathy, neuropathy, nephropathy) and macrovascular (coronary artery disease, peripheral arterial disease, cerebrovascular disease) complications. The present study aims to study the occurrence of microalbuminuria in patients with type II DM and note its association with the duration of diabetes since diagnosis and microvascular complications of DM.
INTRODUCTION
Diabetes mellitus (DM), the most common endocrine disorder, is characterized by metabolic abnormalities and long-term microvascular and macrovascular complications. The prevalence of diabetes is on the rise, and is more alarming in the developing countries. Besides increasing the risks for coronary heart disease, diabetes enhances the incidences of cerebrovascular accidents too. Moreover, it is the leading cause of acquired blindness and accounts for about a quarter of the cases with end-stage renal diseases as well as half of the cases of nontraumatic lower limb amputations.
Diabetic nephropathy occurs in as many as 30% of insulin-dependent DM patients and 25% of noninsulindependent DM patients. Diabetic nephropathy is a dreaded disease with progressive and continuous deterioration in glomerular function resulting in irreversible renal failure. Diabetic nephropathy is an important cause of morbidity and mortality and is now among the most common cause of end-stage renal disease. However, there is an early phase of diabetic renal disease called inci pient diabetic nephropathy. In this stage, there is a rise in urinary excretion of albumin, i.e., microalbuminuria. But, the rise is detectable only by the use of sensitive assays for urinary albumin.
Microalbuminuria is an important warning sign for both the physician and the patient, which, if ignored, can lead to an irreversible renal damage. Microalbuminuria is most commonly associated with other microvascular complications of diabetes, namely retinopathy, neuropathy, and ischemic heart disease. So, microalbuminuria may be a maker for widespread microvascular damage in a patient with DM.
In the current study, we intend to study the occurrence of microalbuminuria in patients with noninsulin-dependent DM and also find out its association with the duration of DM and the microvascular complications of DM.
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MICROVASCULAR COMPLICATIONS
• Eye disease -Retinopathy (proliferative/nonproliferative), macular edema, cataract • Neuropathy -Sensory and motor (mono and poly neuropathy), autonomic neuropathy • Nephropathy.
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MICROALBUMINURIA
This term denotes a significant increase in albumin excretion rate. Albumin excretion in healthy individuals ranges from 1.5 to 20 μg/min with geometric mean in the range of 6.5 μg/min. These values have been termed as normoalbuminuria. Microalbuminuria, thus, defines the wide substantial range of hypersecretion of albumin, ranging between 20 and 200 μg/min. 7 Normal persons excrete less than 30 mg/day of albumin. Microalbuminuria is not detected by reagent sticks for urinary protein, which generally become positive only when protienuria is greater than 550 mg/day. This degree of leakage is termed as macroalbuminuria. 
MATERIALS AND METHODS
A total of 100 patients with noninsulin-dependent DM admitted to RajaRajeswari Medical College & Hospital, Bengaluru, Karnataka, India, were studied. The patients were taken from the medical wards of the hospital based on random selection. Patients were considered to be diabetic based on American Diabetic Association (ADA) criteria for diagnosis of DM, which is • Symptoms of DM plus a random glucose concentration ≥200 mg/dL (11.1 mmol/L). The classic symptoms of DM include polyuria, polydipsia, and unexplained weight loss. OR • Fasting blood glucose ≥126 mg/dL (7.0 mmol/L).
Fasting is defined as no caloric intake for at least 8 hours. OR • 2-hour postprandial glucose ≥200 mg/dL (11.1 mmol/L).
Among diabetics, the above criteria were considered for the inclusion of the patients for the study.
Inclusion Criteria
• The ADA criteria for Type II DM. 
History
• Patients' characteristics, such as age, sex, age of onset, and duration of diabetes.
• All details regarding the present complaints were noted.
• Total duration of diabetes, the drugs the patient was taking, and the dosages were noted. The regularity of the treatment taken by the patients was also noted. The family history regarding diabetes was taken.
• Personal history regarding smoking, alcohol consumption, bowel and bladder habits, and drug intake was noted. A complete clinical examination was carried out in each patient with particular reference to the complications of diabetes like retinopathy, neuropathy, and nephropathy. Height and weight were measured in all cases and body mass index (BMI) was calculated by weight in kg/height in m 2 .
Hypertension was said to be present when there was a history of hypertension or systolic blood pressure was recorded greater than 160 mm Hg and/or diastolic pressure was greater than 90 mm Hg on three consecutive occasions. Peripheral neuropathy was judged to be present if there was historical evidence of neuropathic pain, numbness or tingling sensation in the extremities, or absence of ankle jerks along with diminished vibratory threshold or pinprick sensation in hands or feet on examination. Fundus examination was done in all patients for evidence of diabetic retinopathy. Retinopathy was said to be present when there was evidence of microaneurysm, soft or hard exudates, and hemorrhages. Neovascularity was considered as evidence for proliferative retinopathy.
The following investigations were done in all the patients. 
Estimation of Microalbuminuria by Latex Turbidometric Test
Latex particles coated with specific antibodies, such as antihuman albumin are agglutinated when mixed with samples containing microalbumin. The agglutination causes an absorbable change, dependent on the microalbumin contents of the patient sample that can be quantified by comparison from a calibrator of known microalbumin concentration. Sensitivity of the assay and the target value of the calibrator have been standardized against the international reference material CRM470/ RPPHS.
Specimen Collection
All patients were afebrile during the course of collection of urine and were kept at rest during the collection of urine. The first morning midstream urine sample was collected in a sterile container. Urine of the patient was first tested for albumin by albustix method. Patients who were negative for albumin by the albustix method were only included in this study.
Microalbuminuria was graded as follows: • Mild (20-50 mg/L) = + • Moderate (50-100 mg/L) = ++ • Severe (100-300 mg/L) = +++ Severity of diabetes was graded based on hemoglobin (Hb)A1c levels as follows:
• Mild: <7.0% • Moderate: 7.0 to 7.5% • Severe: >7.5%
Blood urea, serum creatinine, and lipid profile were estimated in all cases.
RESULTS
The results are tabulated from Tables 1 to 7 .
DISCUSSION
Type II DM is being increasingly recognized as a disease, which is characterized by dysfunction of the endothelium. Endothelial dysfunction occurs in a generalized and widespread manner in diabetic subjects. The severity of the dysfunction is directly proportional to the age of the Microalbuminuria marks the onset of endothelial dysfunction related to kidney. Since its original description by Mogensen, the estimation of microalbuminuria has been made easy and practical. Microalbuminuria serves as a warning for imminent nephropathy. However, its true value is that it heralds generalized endothelial dysfunction. Thus, diabetic patients with microalbuminuria not only have ongoing progressive nephropathy, but are also likely to have retinopathy. An effort has been made in this study to highlight this issue. Even among randomly selected patients, an incidence of 38% for microalbuminuria is evident. Among various other studies, the prevalence of microalbuminuria ranges from 25 to 35%. A slight increase in the percentage of microalbuminuria in our study can be attributed to several factors, such as large number of elderly patients, longer duration of diabetes, and poor glycemic control. [7] [8] [9] [10] It is very well recognized that microalbuminuria occurs more commonly in diabetic subjects who are more than 50 years of age. In our study, microalbuminuria tended to be 2.54 times more common in the age group of above 50 years as compared with age group less than 50 years. There are many reasons for this phenomenon. Firstly, deterioration in the β-cell function, which occurs pari-passu with increasing duration of diabetes, is likely to contribute to worsening glycemic control. Poor values of HbA1c are known to be associated with increasing incidence of microalbuminuria. In our study, only 1 out of 5 patients who had normal HbA1c (<7.0%) manifested microalbuminuria, whereas with HbA1c values between 6 and 9.0%, 27 out of 55 patients had microalbuminuria, and in patients with HbA1c >9.0%, 2 out of 10 patients had microalbuminuria. It is seen from the above results that even small increments of HbA1c of more than 6.0% result in almost doubling of the incidence of microalbuminuria.
Although this is a cross-sectional study, these findings raise concern regarding the blatant association between poor glycemic control and microalbuminuria in a rural setting.
This study has also brought out a significant association of microalbuminuria with BMI of more than 25 kg/m 2 .
Of the 22 patients with BMI more than 25, 13 had microalbuminuria (52%). Similar findings have been brought forth by other studies. The possible explanation for this could be [8] [9] [10] :
• Increasing BMI is a reflection of insulin resistance, which, in turn, leads to endothelial dysfunction and microalbuminuria.
• Associated hypertension may also be responsible for microalbuminuria. • Poor glycemic control, which, in turn, is an outcome of insulin resistance, is also held responsible. Our study has also brought out the correlation between lipid parameters and microalbuminuria. Although no relation could be found between microalbuminuria and hypertriglyceridemia and hypercholesterolemia, the incidence of microalbuminuria is 1.93 times more likely for patients who present with high-density lipoporotein (HDL) values less than 35 mg/dL. A similar inverse relationship between HDL and microalbuminuria has been described in many studies. The incidence of microalbuminuria is significantly associated with the presence of retinopathy (p = 0.061), peripheral neuropathy (p = 0.009), hypertension (p ≤ 0.001), and BMI (p = 0.109) more than 25 kg/m 2 .
Peripheral neuropathy and hypertension have the neuropathy dependent on similar risk factors. It is also very well known that retinopathy and microalbuminuria have a high concordance rate.
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CONCLUSION
The occurrence of microalbuminuria is estimated to be 38% in this study. Microalbuminuria shows a direct relationship with increasing age of patients and increasing duration of diabetes since diagnosis. A HbA1c value above 7% is associated with 50% or higher occurrence of microalbuminuria.
Patients with a BMI of more than 25 kg/m 2 have significant increase in microalbuminuria. Occurrence of microalbuminuria is significantly associated with presence of hypertension, neuropathy, retinopathy, and high BMI.
Microalbuminuria is inversely associated with HDL.
